Written and maintained by CASRAI Editorial Board
Published
This page describes products and general use; it is not medical advice.
On this page
Short answer
Chemotherapy PPE (personal protective equipment) refers to specialized barrier gear engineered and tested to protect healthcare and laboratory workers from hazardous antineoplastic drug exposure during receiving, compounding, administration, and spill handling. Regulated under OSHA standards and USP Chapter <800>, it mandates powder-free ASTM D6978 gloves, impermeable back-closing gowns, chemical eye protection, and fit-tested NIOSH respirators.
Definition and scope
Chemotherapy PPE encompasses specialized garments and respiratory barriers designed to prevent occupational exposure to hazardous medications cataloged on the NIOSH hazardous drugs list. Unlike standard clinical PPE intended for pathogen defense, chemotherapy barriers must withstand chemical permeation from genotoxic, carcinogenic, and reproductive toxins.
The operational scope covers critical handling environments:
- Compounding pharmacies: Sterile and non-sterile hazardous drug preparation adhering to USP 800 cleanroom requirements.
- Clinical units: Intravenous infusion, line priming, and oral hazardous drug administration.
- Receiving: Unpacking shipping cartons and managing leaking containers.
- Spill response: Managing chemical releases and decontaminating compounding hoods.
- Patient waste: Handling bodily fluids from patients treated with antineoplastics within 48 hours.
Oversight derives from OSHA under 29 CFR 1910.132 (PPE) and 29 CFR 1910.134 (Respiratory Protection), alongside United States Pharmacopeia General Chapter <800> standards.
How it works or how it is used in practice
Chemotherapy PPE provides a physical barrier against chemical permeation and aerosols. Because dermal contact is the primary route of occupational uptake, barrier components follow strict engineering standards.
Chemotherapy Gloves (ASTM D6978)
Gloves must satisfy ASTM D6978 (Standard Practice for Assessment of Resistance of Medical Gloves to Permeation by Chemotherapy Drugs). ASTM D6978 is far stricter than general medical glove standards (ASTM D6319) or European chemical benchmarks (EN 16523-1):
- Permeation threshold: Enforces a breakthrough permeation rate of 0.01 µg/cm²/min—100 times more protective than the 1.0 µg/cm²/min threshold in EN 16523-1.
- Skin temperature testing: Tested at 35 ± 2 °C to replicate human skin temperature, rather than ambient room temperature (23 ± 1 °C), reflecting accelerated chemical diffusion in use.
- Vulnerable zones: Specifically targets the thinnest area of the glove.
- Test panel: Assesses baseline antineoplastics including carmustine, cyclophosphamide, doxorubicin, fluorouracil, cisplatin, etoposide, and paclitaxel.
Double-gloving is mandatory for compounding, administration, and spill control. The inner glove rests beneath the gown cuff; the outer glove extends over the cuff. Outer gloves must be inspected before use and replaced every 30 minutes during compounding, or immediately if compromised. Staff reference a glove compatibility chart for drug-specific breakthrough times.
Chemotherapy Gowns
Gowns must be disposable, lint-free, and made from low-permeability coated fabrics (such as polyethylene-coated polypropylene). Gowns require a closed front, back closure, long sleeves, and snug knit or elastic cuffs. Cloth lab coats and open-back gowns are prohibited because they absorb hazardous fluids. Gowns must be changed every 2 to 3 hours, or immediately if contaminated.
Eye, Face, and Respiratory Protection
Full face shields or chemical splash goggles (ANSI/ISEA Z87.1) are required whenever splash risks exist. Regular eyeglasses lack adequate lateral splash protection.
Surgical masks do not filter chemical vapors or hazardous drug aerosols. When responding to spills or opening damaged packaging, staff must wear fit-tested NIOSH-certified respirators (N95, N100, or PAPR) under an OSHA respiratory program (29 CFR 1910.134).
Hand Hygiene Protocol
Washing with soap and water is mandatory immediately after removing gloves. Alcohol rubs do not neutralize antineoplastic residues and may enhance transdermal absorption.
Types or related concepts
Chemotherapy PPE configurations vary by operational task. The matrix below outlines minimum PPE requirements under OSHA directives and USP Chapter <800>:
| Operational Task | Glove Layering | Gown Specification | Eye & Face Protection | Respiratory Barrier |
|---|---|---|---|---|
| Receiving Intact Cartons | Single ASTM D6978 glove | Not required if carton intact | Not required for routine handling | Not required for sealed cartons |
| Receiving Damaged / Leaking Vials | Double ASTM D6978 gloves | Impermeable poly-coated gown | Chemical splash goggles or shield | Fit-tested NIOSH N95 respirator |
| Sterile Compounding (in C-PEC) | Double ASTM D6978 (outer sterile) | Lint-free, poly-coated gown | Face shield if outside BSC sash | Fit-tested N95 during cleaning |
| Bedside IV Administration | Double ASTM D6978 gloves | Impermeable poly-coated gown | Face shield if splash risk exists | N95 if aerosol risk exists |
| Spill Cleanup & Remediation | Double ASTM D6978 gloves | Impermeable gown or coverall | Full face shield and goggles | Fit-tested respirator or PAPR |
| Patient Excreta Care (<48 Hours) | Double ASTM D6978 gloves | Impermeable back-closing gown | Face shield if splash anticipated | Droplet mask if splash anticipated |
Trace-contaminated PPE must be discarded into yellow chemotherapy containers upon removal. Items soaked from gross spills require disposal as bulk hazardous waste under chemotherapy waste disposal and pharmaceutical waste disposal regulations.
Where it matters for labs, clinics or supply decisions
Chemotherapy PPE procurement carries legal and safety obligations under federal oversight.
The FDA classifies chemotherapy gloves under 21 CFR § 880.6250 as Class I specialty medical devices (Product Code: LZC). To market gloves with chemotherapy protection labeling, manufacturers must clear a 510(k) premarket notification demonstrating ASTM D6978 permeation data. Healthcare buyers must verify that vendor packaging explicitly identifies FDA 510(k) clearance and ASTM D6978 testing rather than generic industrial certifications.
Key procurement considerations include:
- Permeation verification: Review vendor matrices for fast penetrators like carmustine and thiotepa to set operational change intervals.
- Sterile versus non-sterile: Stock sterile ASTM D6978 gloves for cleanroom compounding and non-sterile pairs for nursing administration.
- Material selection: Powder-free nitrile and polychloroprene eliminate latex allergy risks while maintaining tactile dexterity.
- Storage controls: Store supplies away from heat and UV light to prevent accelerated polymer degradation.
Common misunderstandings
Addressing common misconceptions helps prevent accidental exposure:
1. Standard exam gloves protect against oral chemotherapy.
Standard exam gloves certified under ASTM D6319 lack ASTM D6978 chemical permeation testing. Antineoplastic agents can penetrate standard exam gloves within minutes. ASTM D6978 gloves are required even when dispensing intact oral tablets.
2. Alcohol hand sanitizers clean hands after doffing.
Alcohol does not degrade antineoplastic molecules and may increase skin permeability. Staff must wash with soap and water, using mechanical friction to rinse away chemical residues.
3. Surgical masks filter antineoplastic aerosols.
Surgical masks capture large expelled droplets but do not seal against the face or filter hazardous vapors. Only fit-tested NIOSH respirators provide verified inhalation defense.
4. Reusable cloth gowns are acceptable during compounding.
Cloth garments absorb hazardous liquid spills and shed airborne lint that compromises cleanroom sterility. USP <800> requires disposable, poly-coated, lint-free gowns.
5. Chemotherapy PPE is only needed during active infusion.
Hazardous drug residue is common on shipping packaging and patient waste up to 48 hours post-infusion. Protective equipment is required throughout receiving, handling, and waste disposal.
FAQ
What is the difference between ASTM D6978 and ASTM F739?
ASTM F739 evaluates general chemical permeation at 1.0 µg/cm²/min at 23 °C. ASTM D6978 enforces a 100-fold more sensitive threshold (0.01 µg/cm²/min) at skin temperature (35 °C) against antineoplastic drugs.
How often must chemotherapy gloves and gowns be changed?
Outer gloves must be changed every 30 minutes during continuous compounding, or immediately if torn or contaminated. Gowns must be changed every 2 to 3 hours or immediately following a spill or splash.
Why is double-gloving required for antineoplastic drugs?
Double-gloving provides redundancy against pinhole breaches, maintains a secure cuff seal (inner under cuff, outer over cuff), and permits safe removal of contaminated outer gloves without exposing bare skin.
Can chemotherapy gowns be laundered and reused?
No. Chemotherapy gowns must be single-use and disposable. Laundering breaks down barrier coatings and risks contaminating laundry equipment and personnel.
Where should used chemotherapy PPE be discarded?
Trace-contaminated PPE must be discarded into designated yellow trace chemotherapy containers. Items saturated with gross chemical spills must be disposed of as bulk hazardous waste in black containers.
Sources
- Occupational Safety and Health Administration (OSHA). “Controlling Occupational Exposure to Hazardous Drugs.” OSHA Safety and Health Topics. https://www.osha.gov/hazardous-drugs/controlling-occex. Read date: 2026-11-10.
- U.S. Food and Drug Administration (FDA). “Medical Glove, Specialty (Product Code LZC, 21 CFR § 880.6250).” openFDA Device Classification Database. https://api.fda.gov/device/classification.json?search=product_code:LZC. Read date: 2026-11-10.
- National Center for Biotechnology Information (NCBI) / PubMed Central. “Gloves Standards and Occupational Exposure to Antineoplastic Drugs in the European Context.” Health Science Reports, March 2025; PMC11931325. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11931325/. Read date: 2026-11-10.
- United States Pharmacopeial Convention (USP). “General Chapter <800>: Hazardous Drugs—Handling in Healthcare Settings.” Compendial Standards Summary. Read date: 2026-11-10.







